ABVC Biopharma Inc (ABVC) — Working Capital to Net Assets Ratio

Latest as of December 2025: -27.5%

ABVC Biopharma Inc (ABVC) has a Working Capital to Net Assets ratio of -27.5% as of December 2025. Working capital of $-3.66 Million (current assets of $2.50 Million minus current liabilities of $6.16 Million) is measured against net assets of $13.30 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See ABVC net asset quality index to measure how much of total assets are equity-financed.

WC/NA Ratio

-27.5%
Working Capital / Net Assets

Working Capital

$-3.66 Million
USD

Current Assets

$2.50 Million
USD

Current Liabilities

$6.16 Million
USD

ABVC Biopharma Inc Working Capital to Net Assets (2002–2025)

This chart shows how ABVC Biopharma Inc's Working Capital to Net Assets ratio has evolved across 22 annual periods from 2002 to 2025. As of December 2025, the ratio stands at -27.5%, reflecting working capital of $-3.66 Million against net assets of $13.30 Million USD. Check tangible equity quality of ABVC Biopharma Inc to evaluate the tangible quality of the company's equity base.

Annual Working Capital to Net Assets for ABVC Biopharma Inc (2002–2025)

The table below presents the year-by-year Working Capital to Net Assets ratio for ABVC Biopharma Inc from 2002 to 2025, covering 22 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see ABVC Biopharma Inc (ABVC) market capitalisation.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2025 -27.5% $-3.66 Million $13.30 Million $2.50 Million $6.16 Million ▲ +577.1 pp
2024 -604.7% $-4.38 Million $723.96K $2.18 Million $6.56 Million ▼ -250.1 pp
2023 -354.6% $-4.45 Million $1.25 Million $1.66 Million $6.10 Million ▼ -298.9 pp
2022 -55.7% $-2.56 Million $4.59 Million $2.99 Million $5.54 Million ▼ -100.3 pp
2021 44.7% $3.96 Million $8.87 Million $7.65 Million $3.69 Million ▲ +21.8 pp
2020 22.8% $1.33 Million $5.82 Million $6.17 Million $4.84 Million ▼ -4732.9 pp
2019 4755.7% $-5.94 Million $-124.82K $878.24K $6.81 Million ▲ +4660.6 pp
2018 95.2% $-5.47 Million $-5.75 Million $96.27K $5.57 Million ▲ +230.4 pp
2017 -135.3% $-3.33 Million $2.46 Million $760.97K $4.09 Million ▼ -235.3 pp
2016 100.0% $-6.52 Million $-6.52 Million $18.64K $6.54 Million ▲ +222.1 pp
2015 -122.1% $-35.52K $29.08K $3.63K $39.15K ▼ -16.9 pp
2014 -105.3% $-32.17K $30.56K $1.86K $34.03K ▼ -223.5 pp
2011 118.3% $-1.73 Million $-1.46 Million $101.92K $1.83 Million ▲ +9.6 pp
2010 108.7% $-3.25 Million $-2.99 Million $33.15K $3.29 Million ▼ -17.0 pp
2009 125.7% $-2.53 Million $-2.01 Million $1.40K $2.53 Million ▼ -14.8 pp
2008 140.5% $-1.74 Million $-1.24 Million $999.48K $2.74 Million ▲ +152.1 pp
2007 -11.6% $-33.67K $290.29K $880.17K $913.84K ▼ -111.6 pp
2006 100.0% $35.27K $35.27K $88.34K $53.07K ▲ +0.0 pp
2005 100.0% $60.67K $60.67K $63.40K $2.72K ▲ +0.0 pp
2004 100.0% $87.34K $87.34K $90.31K $2.96K ▲ +0.0 pp
2003 100.0% $80.00K $80.00K $110.00K $30.00K ▲ +0.0 pp
2002 100.0% $10.00K $10.00K $40.00K $30.00K
pp = percentage points